164 related articles for article (PubMed ID: 19825429)
21. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
Dong Y; Rohn WM; Benveniste EN
J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014
[TBL] [Abstract][Full Text] [Related]
22. Mycoplasma fermentans-derived lipid inhibits class II major histocompatibility complex expression without mediation by interleukin-6, interleukin-10, tumor necrosis factor, transforming growth factor-beta, type I interferon, prostaglandins or nitric oxide.
Frisch M; Gradehandt G; Mühlradt PF
Eur J Immunol; 1996 May; 26(5):1050-7. PubMed ID: 8647166
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
[TBL] [Abstract][Full Text] [Related]
24. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
Meissner M; Whiteside TL; Kaufmann R; Seliger B
Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
Radosevich M; Jager M; Ono SJ
Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
[TBL] [Abstract][Full Text] [Related]
26. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
[TBL] [Abstract][Full Text] [Related]
27. Revisiting the specificity of the MHC class II transactivator CIITA in vivo.
Otten LA; Leibundgut-Landmann S; Huarte J; Kos-Braun IC; Lavanchy C; Barras E; Borisch B; Steimle V; Acha-Orbea H; Reith W
Eur J Immunol; 2006 Jun; 36(6):1548-58. PubMed ID: 16703565
[TBL] [Abstract][Full Text] [Related]
28. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
[TBL] [Abstract][Full Text] [Related]
29. MHC class II transcription in different mouse cell types. Differential requirement for protein synthesis between B cells and macrophages.
Woodward JG; Omer KW; Stuart PM
J Immunol; 1989 Jun; 142(11):4062-9. PubMed ID: 2497189
[TBL] [Abstract][Full Text] [Related]
30. The arginine methyltransferase PRMT5 regulates CIITA-dependent MHC II transcription.
Fan Z; Kong X; Xia J; Wu X; Li H; Xu H; Fang M; Xu Y
Biochim Biophys Acta; 2016 May; 1859(5):687-96. PubMed ID: 26972221
[TBL] [Abstract][Full Text] [Related]
31. Roles of PU.1 in monocyte- and mast cell-specific gene regulation: PU.1 transactivates CIITA pIV in cooperation with IFN-gamma.
Ito T; Nishiyama C; Nakano N; Nishiyama M; Usui Y; Takeda K; Kanada S; Fukuyama K; Akiba H; Tokura T; Hara M; Tsuboi R; Ogawa H; Okumura K
Int Immunol; 2009 Jul; 21(7):803-16. PubMed ID: 19502584
[TBL] [Abstract][Full Text] [Related]
32. Adenosine signaling inhibits CIITA-mediated MHC class II transactivation in lung fibroblast cells.
Fang M; Xia J; Wu X; Kong H; Wang H; Xie W; Xu Y
Eur J Immunol; 2013 Aug; 43(8):2162-73. PubMed ID: 23681904
[TBL] [Abstract][Full Text] [Related]
33. Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10.
O'Keefe GM; Nguyen VT; Benveniste EN
Eur J Immunol; 1999 Apr; 29(4):1275-85. PubMed ID: 10229095
[TBL] [Abstract][Full Text] [Related]
34. Failure of MHC class II expression in neonatal alveolar macrophages: potential role of class II transactivator.
Lee PT; Holt PG; McWilliam AS
Eur J Immunol; 2001 Aug; 31(8):2347-56. PubMed ID: 11477547
[TBL] [Abstract][Full Text] [Related]
35. IFN-gamma-dependent transcription of MHC class II IA is impaired in macrophages from aged mice.
Herrero C; Marqués L; Lloberas J; Celada A
J Clin Invest; 2001 Feb; 107(4):485-93. PubMed ID: 11181648
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.
Ghorpade DS; Holla S; Sinha AY; Alagesan SK; Balaji KN
J Biol Chem; 2013 Jul; 288(28):20592-606. PubMed ID: 23733190
[TBL] [Abstract][Full Text] [Related]
37. Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and neuroblastoma.
Yazawa T; Ito T; Kamma H; Suzuki T; Okudela K; Hayashi H; Horiguchi H; Ogata T; Mitsui H; Ikeda M; Kitamura H
Am J Pathol; 2002 Jul; 161(1):291-300. PubMed ID: 12107114
[TBL] [Abstract][Full Text] [Related]
38. Diverse mechanisms employed by Toxoplasma gondii to inhibit IFN-gamma-induced major histocompatibility complex class II gene expression.
Lang C; Algner M; Beinert N; Gross U; Lüder CG
Microbes Infect; 2006 Jul; 8(8):1994-2005. PubMed ID: 16824778
[TBL] [Abstract][Full Text] [Related]
39. Protein arginine methyltransferase 1 (PRMT1) represses MHC II transcription in macrophages by methylating CIITA.
Fan Z; Li J; Li P; Ye Q; Xu H; Wu X; Xu Y
Sci Rep; 2017 Jan; 7():40531. PubMed ID: 28094290
[TBL] [Abstract][Full Text] [Related]
40. Amelogenin Downregulates Interferon Gamma-Induced Major Histocompatibility Complex Class II Expression Through Suppression of Euchromatin Formation in the Class II Transactivator Promoter IV Region in Macrophages.
Yotsumoto K; Sanui T; Tanaka U; Yamato H; Alshargabi R; Shinjo T; Nakao Y; Watanabe Y; Hayashi C; Taketomi T; Fukuda T; Nishimura F
Front Immunol; 2020; 11():709. PubMed ID: 32373130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
